Setting the standard for Inhaled Nicotine Replacement Therapies
Liber aims to prove the safety and efficacy of inhalation-based therapies as methods of administering medicines.
Through its suite of inhaled Nicotine Replacement Therapy (iNRT) products, Liber is focused on vaporiser technology as an intervention for smoking cessation.
The
Liber
difference
01
Locally supplied and insured
Liber is the only Nicotine Vaping Product (NVP) manufacturer who has acquired Australian-issued product liability insurance.
02
Characterised and assessed liquids
Characterisation of all flavour compounds, subjected to comprehensive toxicological risk and hazard assessments for inhalation.
03
Domestic pharmacy distribution
Nicovape® Q is the only NVP supplied by pharmaceutical wholesalers (Symbion and API) to over 5,500 community pharmacies nationwide.
Find us in your local pharmacy
Over 2,000 community pharmacies nationwide currently hold stock of the Nicovape® Q range in-store.
Interested in stocking Nicovape® Q?
Speak with your national wholesaler SAS representative
Vaping safety and user’s trust – why regulation matters
Would you feel better knowing that your device was manufactured to the highest possible standards?
Postcard from America – vaping mistakes
How one of vaping’s biggest success stories became a reputational nightmare, and how not to repeat the same mistakes in Australia.
Find us in your local pharmacy
Over 2,000 community pharmacies nationwide currently hold stock of the Nicovape® Q range in-store.
Interested in stocking Nicovape® Q?
Speak with your national wholesaler SAS rep
Vaping safety and user’s trust – why regulation matters
Would you feel better knowing that your device was manufactured to the highest possible standards?
Postcard from America – vaping mistakes
How one of vaping’s biggest success stories became a reputational nightmare, and how not to repeat the same mistakes in Australia.